임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

13건 표시

1상모집 중단 (진행 중)· Healthy Participants
Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose
리드: 암젠
상세 →NCT07422285
1상모집 중단 (진행 중)· Overweight
Effect of Maridebart Cafraglutide on the Heart's Electrical Activity
리드: 암젠
상세 →NCT07229157
1상모집 중단 (진행 중)· Type 2 Diabetes Mellitus
A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
리드: 암젠
상세 →NCT07160257
1상모집 중단 (진행 중)· Small Cell Lung Cancer
Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)
리드: 암젠
상세 →NCT06898957
1상모집 중단 (진행 중)· Asthma
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
리드: 암젠
상세 →NCT06637371
1상모집 중단 (진행 중)· Prostate Cancer
Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer
리드: 암젠
상세 →NCT06555796
1상모집 중단 (진행 중)· Thoracic Tumors
Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).
리드: 암젠
상세 →NCT06333951
1상모집 중단 (진행 중)· Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)
리드: 암젠
상세 →NCT06360354
1상모집 중단 (진행 중)· Advanced Solid Tumors
A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
리드: 암젠
상세 →NCT06131398
1상모집 중단 (진행 중)· Extensive Stage Small Cell Lung Cancer
First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
리드: 암젠
상세 →NCT05361395
1상모집 중단 (진행 중)· Advanced Solid Tumors
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
리드: 암젠
상세 →NCT04185883
1상모집 중단 (진행 중)· Small Cell Lung Carcinoma
Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)
리드: 암젠
상세 →NCT03319940
1상모집 중단 (진행 중)· CD20 Positive
Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma
협력: 암젠
상세 →NCT01959698

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.